Category: Narcotics
04. Mar 2026
How Drug Analysis Delays Affect Officer Morale
Introduction: The Growing Problem of Case Delays Drug case processing delays are often caused by capacity constraints during investigations, forensic testing, and court proceedings. These delays slow the progression from arrest to final disposition, creating challenges for law enforcement and the justice system. Research indicates that increasing submission volumes have
30. Oct 2025
What Is Pink Cocaine (Tusi)? The Hidden Dangers
The Rise of Pink Cocaine Pink cocaine, a synthetic designer drug, has recently attracted media attention and scientific attention, especially when it comes to its associated dangers. However, the reality is that this drug is neither new nor is it cocaine; it contains a blend of various existing substances and
22. Jul 2025
Rapid Detection and Quantification of Falsified Viagra
Using Cloud-Based Portable NIR Technology and Machine Learning Reference: Hervé Rais, Pierre Esseiva, Olivier Delémont, Cédric Schelling, Stefan Stanojevic, Serge Rudaz, Florentin Coppey, Rapid detection and quantification of falsified Viagra using cloud-based portable NIR technology and machine learning, Journal of Pharmaceutical and Biomedical Analysis, Volume 263, 2025, 116940, ISSN 0731-7085, https://doi.org/10.1016/j.jpba.2025.116940.
08. Aug 2024
Use of Portable NIR Technology for Drug analysis in Australia
The challenge of efficiently and accurately analyzing illicit drugs remains significant in Australia due to the high volume of drugs trafficked within the country. A recent study explores the potential of Near-Infrared (NIR) spectroscopy combined with machine learning.1 Hence, by using NIRLAB’s solution to provide rapid and accurate drug identification
27. Jun 2024
Current Drug Situation in Europe 2024: An Insightful Analysis
The drug landscape in Europe is continually evolving, driven by the emergence of new substances, shifting usage patterns, and changing policies. The European Drug Report 20241 highlights these dynamics and underscores the need for a multifaceted response to drug-related challenges. This article offers a comprehensive analysis of the current drug
